Category: HeartWare International Inc.Syndicate content

LVADs: Thoratec study a Roadmap to lower-risk patients?

April 20, 2015 by Brad Perriello

Results from Thoratec's Roadmap study of its HeartMate II implantable heart pump in less-sick heart failure patients shows significant benefit over optimal medical therapy alone.

LVADs: Thoratec study a Roadmap to lower-risk patients

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

HeartWare slides on stroke results from heart pump studies

April 16, 2015 by Brad Perriello

Higher-than-expected stroke rates reported in a pair of studies of HeartWare's implantable heart pump this week spook investors, pushing HTWR share prices down more than 8%.

HeartWare slides on stroke results from heart pump studies

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

FDA finalizes fast track for devices | Regulatory news for the week of April 13, 2015

April 14, 2015 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week: FDA finalizes fast-track approval for medical devices; CardiAQ Valve wins FDA nod for mitral valve trial; HemCon enters Chinese wound care market; HeartWare wins Health Canada nod for BTT heart pump; Another FDA warning letter for Hospira

FDA finalizes fast-track approval for medical devices

April 9, 2015 by Brad Perriello

HeartWare wins Health Canada nod for BTT heart pump

April 9, 2015 by Mark Hollmer

Canadian regulators approved HeartWare International's ventricular assist device as a bridge to heart transplant for patients with end-stage heart failure.

HeartWare wins Health Canada nod for BTT heart pump

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

HeartWare issues urgent recall for heart-pump controllers

February 23, 2015 by Val Kennedy

HeartWare International has issued an urgent recall for certain computerized controllers for its ventricular assist devices over concerns that they may malfunction and cause the heart pump to stop.

U.S. sales narrow HeartWare's Q3 losses

HeartWare International (NSDQ:HTWR) has issued an urgent recall for certain computerized controllers for its ventricular assist devices over concerns that they may malfunction and cause the heart pump to stop.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

HeartWare beats on Q4 prelims, launches thoracotomy trial

January 13, 2015 by Brad Perriello

HeartWare International's preliminary sales numbers for the 4th quarter beat expectations as it launches a thoracotomy trial for its implantable heart pump.

HeartWare beats on Q4 prelims, launches thoracotomy trial

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

LVAD slump? Thoratec dims outlook after Q3 earnings plunge

November 6, 2014 by Brad Perriello

Thoratec's 3rd-quarter earnings plunge nearly 85% as sales decline more than 16%, raising fears that the left ventricular-assist device market is in a slump that could persist into 2015.

LVAD slump? Thoratec dims outlook after Q3 earnings plunge

Thoratec (NSDQ:THOR) yesterday said its 3rd-quarter profits plunged some 85%, missing forecasts, and dimmed its outlook for the rest of the year.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.